Bloomberg.comAstraZeneca Eyes Gilead in Big Pharma’s Move Beyond CovidJun 8, 2020By John Lauerman, ed hammond & Suzi RingMore
Bloomberg.comAstraZeneca Approaches Gilead About Potential MergerJun 7, 2020By ed hammond, Aaron Kirchfeld & Dinesh NairMore